FIELD: medicine.
SUBSTANCE: invention refers to medicine. There is disclosed capsule containing various reactant pellets differing with reactant release profile in gastrointestinal tract and containing at least two various reactants specified from vitamin complexes, mineral matters, microelements, unsaturated fatty acids, amino acids and/or vegetative extracts and substances. Differing reactant release profiles are related to fast, average and/or slow dissolution of reactant pellets. Such controlled reactant release provides stable absorption in various and optimum gastrointestinal parts.
EFFECT: dosage form offered in the invention allows improving essentially reactant bioavailability even in increased amounts.
14 cl, 5 dwg, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| ORAL COMPOSITION WITH CONTROLLED RELEASE BIOLOGICALLY ACTIVE SUBSTANCES | 2006 |
|
RU2410085C2 |
| OPTOMISED VITAMIN-MINERAL COMPLEX | 2010 |
|
RU2423108C1 |
| DOUBLE-LAYER VITAMIN B TABLETS AND A METHOD FOR PRODUCTION THEREOF | 2017 |
|
RU2732029C2 |
| MEDICINE CONTAINING 3-(3-DIMETHYLAMINE-1-ETHYL-2-METHYLPROPYL) PHENOL WITH PROLONGED RELEASE OF REACTANT | 2002 |
|
RU2325905C2 |
| SOLID PER ORAL MEDICATION, CONTAINING INTENSIFIER | 2007 |
|
RU2437662C2 |
| SOLID COMPOSITIONS CONTAINING 5-AMINOLEVULINIC ACID | 2010 |
|
RU2527328C2 |
| pH-CONTROLLED PULSE DELIVERY SYSTEMS, METHODS FOR PRODUCING AND USING THEREOF | 2005 |
|
RU2412694C2 |
| MEDICINAL FORMS ON BASIS OF BIPHOSPHONATES | 2005 |
|
RU2359678C2 |
| PHARMACEUTICAL MEDICINAL FORM, RESISTANT TO GASTRIC JUICE ACTIVITY, WHICH INCLUDES N-(2-(2-PHTHALIMIDOETOXY)ACETYL)-L-ALANYL-D-GLUTAMIC ACID (LK 423) | 2005 |
|
RU2375047C2 |
| PHARMACEUTICAL COMPOSITIONS OF RHEIN OR DIACEREIN | 2008 |
|
RU2484816C2 |
